# Layer 13: Academic Frontier (The Future)

## ğŸ§¬ THE Signal
Scientific publication and depth. If a biotech firm is published on **Google Scholar** with 10+ papers on "mRNA Delivery," they are the global leaders in that niche.

## ğŸ¯ Target Customers (Who will buy this data?)
1.  **Pharma / Biotech Investors**: Find the researchers behind the next breakthrough therapy.
2.  **Lab Supply Vendors**: Identify companies with active R&D publication cycles (they need equipment).
3.  **Headhunters for R&D**: Poaching the top academic talent from internal corporate labs.

## ğŸ› ï¸ Profitable Search Patterns
- `site:scholar.google.com "AstraZeneca" research papers`
- `site:researchgate.net "BioNTech" publications`
- `site:pubmed.ncbi.nlm.nih.gov "Moderna" oncology`

## ğŸ’ The "Omega" Advantage

## ğŸŒŠ Zero Vacuum Strategy (100% Coverage Plan)

### Free Sources Implemented
- [x] PubMed API (Med/Bio)
- [x] arXiv API (CS/Physics)
- [x] Semantic Scholar
- [x] ResearchGate

### Paid Sources Reserve (Future)
- Web of Science
- Scopus (Elsevier)
- DeepDyve

## ğŸ¯ Expanded Market Opportunities
1. **Pharmaceutical Sales**: Targeting labs publishing on specific pathways.
2. **University Recruiters**: Finding PhD candidates.
3. **Scientific Instrument Vendors**: Selling microscopes/sequencers to active labs.
4. **Venture Studios**: Finding IP to commercialize from universities.
